About Manifold Bio
Manifold Bio is a company based in United States founded in 2018 by Gleb Kuznetsov, Shane Lofgren, Pierce Ogden, and George M Church.. Manifold Bio has raised $78.19 million across 3 funding rounds from investors including Tencent, Triatomic Capital and Future Perfect Ventures. The company has 22 employees as of December 31, 2022. Manifold Bio offers products and services including Tissue-Targeted Biologics and mCodes Technology.
- Headquarter United States
- Employees 22 as on 31 Dec, 2022
- Founders Gleb Kuznetsov, Shane Lofgren, Pierce Ogden, George M Church
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Manifold Bio, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$78.19 M (USD)
in 3 rounds
-
Latest Funding Round
$32.78 M (USD), Series A
Nov 18, 2024
-
Investors
Tencent
& 8 more
-
Employee Count
22
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Manifold Bio
Manifold Bio offers a comprehensive portfolio of products and services, including Tissue-Targeted Biologics and mCodes Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Targeted biologics are developed using high-throughput in vivo screening and AI to optimize pharmacokinetics and biodistribution for tissue-specific delivery
mCodes technology is utilized as multiplexed protein barcodes for tracking and measuring biologics across tissues with high sensitivity
Unlock access to complete
Unlock access to complete
Funding Insights of Manifold Bio
Manifold Bio has successfully raised a total of $78.19M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $32.78 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $32.8M
-
First Round
First Round
(10 Aug 2020)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2024 | Amount | Series A - Manifold Bio | Valuation |
investors |
|
| Jun, 2022 | Amount | Series A - Manifold Bio | Valuation | Triatomic | |
| Aug, 2020 | Amount | Seed - Manifold Bio | Valuation | Playground Global |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Manifold Bio
Manifold Bio has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Tencent, Triatomic Capital and Future Perfect Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Triatomic Capital is focused on investing in century-defining technological themes.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on blockchain technology sectors
|
Founded Year | Domain | Location | |
|
Horizons Ventures is focused on investing in deep science and technology.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Manifold Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Manifold Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Manifold Bio Comparisons
Competitors of Manifold Bio
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Manifold Bio
When was Manifold Bio founded?
Manifold Bio was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Where is Manifold Bio located?
Manifold Bio is headquartered in United States.
Who is the current CEO of Manifold Bio?
Gleb Kuznetsov is the current CEO of Manifold Bio. They have also founded this company.
Is Manifold Bio a funded company?
Manifold Bio is a funded company, having raised a total of $78.19M across 3 funding rounds to date. The company's 1st funding round was a Seed of $5.4M, raised on Aug 10, 2020.
How many employees does Manifold Bio have?
As of Dec 31, 2022, the latest employee count at Manifold Bio is 22.
What does Manifold Bio do?
Manifold Bio was founded in 2018 and is based in the United States. Operations focus on the biotechnology sector, where pharmacological assessments of therapeutic protein variants are performed. The lab supports drug development through precise measurements and analysis. Key leadership includes co-founders Gleb Kuznetsov as CEO, Shane Lofgren, Pierce Ogden as CSO, and George M. Church. Research activities are centered on advancing protein-based therapeutics.
What products or services does Manifold Bio offer?
Manifold Bio offers Tissue-Targeted Biologics and mCodes Technology.
Who are Manifold Bio's investors?
Manifold Bio has 9 investors. Key investors include Tencent, Triatomic Capital, Future Perfect Ventures, Horizons Ventures, and Fifty Years.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.